Ontada, a division of McKesson, is an oncology data, research and technology company that is on a mission to transform cancer care. Our ownership of the leading oncology-specific electronic health record, iKnowMed, means we provide life sciences companies with data that reflects insights into physician behavior in near real-time, as the oncology standard of care changes. But what truly sets us apart is our deep-rooted connection to the largest community oncology network in the country, The U.S. Oncology Network, (The Network), which treats 1 in 5 cancer patients. This partnership is foundational to all our solutions. By leveraging this connection, we provide life sciences companies with diverse and representative data that reflects the care received in the community, where an estimated 85% of cancer patients seek care. It also allows us to provide our customers with clinical and research support from practicing oncologists for real-world research studies. Working directly with The Networks’ oncologists and staff we provide life sciences with the opportunity to communicate important brand, clinical and product specific messages through our Ontada Learn offerings. Bolstered by McKesson’s larger oncology ecosystem which includes the Sarah Cannon Research Institute, a leading oncology research organization and Genospace, a clinical trial matching technology, Ontada is well positioned to deliver actionable insights and drive innovation in the life sciences industry, ultimately contributing to the advancement of patient care in oncology.